Concepedia

Publication | Open Access

Insulin Degludec in Type 1 Diabetes

DOIFull Paper Access

160

Citations

14

References

2011

Year

Kåre I. Birkeland, Philip Home, Ulrich Wendisch, Robert E. Ratner, Thue Johansen, Lars Endahl, Karsten Lyby, Johan Jendle, Anthony P. Roberts, J. Hans DeVries,
Diabetes Care

Abstract

In this clinical exploratory phase 2 trial in people with type 1 diabetes, IDeg is safe and well tolerated and provides comparable glycemic control to IGlar at similar doses, with reduced rates of hypoglycemia.

References

YearCitations

Page 1